Sandoz initiates voluntary recall in the US of all 50mg/2mL and 250mg/10mL vials of Methotrexate Injection, USP due to the presence of glass particulates
Sandoz Inc. announced today it has initiated a voluntary recall in the US of all 50mg/2mL and 250mg/10mL vials of Sandoz and Parenta brand Methotrexate Injection, USP product ( methotrexate ) to the consumer/user level. Consistent with its commitment to quality and patient safety, Sandoz is initiating this voluntary recall of all 24 lots of the affected product following the finding of small glass flakes by Sandoz quality control in a limited number of vials in four lots. The flakes are the result of delamination of the glass used to manufacture the vials of these two dosage presentations.

bioM rieux, Inc. Issues Urgent Product Correction for VITEK 2 Gram Negative Susceptibility Cards Containing Piperacillin/Tazobactam
bioM rieux, Inc. on September 16, 2010, initiated a worldwide voluntary product correction of VITEK 2 Gram Negative Susceptibility Cards containing the antibiotic Piperacillin/Tazobactam (TZP ). These cards, manufactured after March 10, 2009, are used in clinical laboratories to perform antimicrobial susceptibility testing as part of the VITEK 2 System.